Ranade Rohit, Rachh Swati, Basu Sandip
Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Parel, Mumbai, India; and.
Department of Nuclear Medicine, Gujarat Cancer and Research Institute, Ahmedabad, India.
J Nucl Med Technol. 2015 Sep;43(3):231-3. doi: 10.2967/jnmt.114.149294. Epub 2014 Dec 23.
Malignant transformation of struma ovarii is a rare event observed in about 5% of cases. We present here an unusual case that closely simulated highly differentiated follicular carcinoma, an entity with a relatively similar appearance to malignant struma ovarii. In our case, peritoneal and systemic dissemination occurred 18 y after excision of struma ovarii, which had been reported as histopathologically benign. There were 3 noteworthy features in the case: the highly functioning nature of the lesions (evidenced by a low level of thyroid-stimulating hormone even without thyroxine suppression); the low to minimal (18)F-FDG avidity of the foci, which reiterates the well-differentiated nature of these lesions, as expected in highly differentiated follicular carcinoma; and prominent involvement of rare sites such as spleen and liver, in addition to usual sites such as lungs, peritoneum, and bilateral adnexae.
卵巢甲状腺肿的恶性转化是一种罕见事件,约5%的病例会出现。我们在此呈现一例不寻常的病例,该病例酷似高分化滤泡癌,这是一种外观与恶性卵巢甲状腺肿相对相似的实体。在我们的病例中,卵巢甲状腺肿切除术后18年出现了腹膜和全身播散,该卵巢甲状腺肿的组织病理学报告为良性。该病例有3个值得注意的特征:病变的高功能性质(即使在没有甲状腺素抑制的情况下,促甲状腺激素水平也较低可证明);病灶的(18)F-FDG摄取低至最小,这再次表明这些病变具有高分化性质,这在高分化滤泡癌中是预期的;除了肺、腹膜和双侧附件等常见部位外,脾脏和肝脏等罕见部位也有明显受累。